Harwood; Eric

Patent Applications and Registrations

Patent applications and USPTO patent grants for Harwood; Eric.The latest application filed is for "pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties".

Company Profile

0.8.20

Harwood; Eric - Seattle WA US
Harwood; Eric - Emeryville CA
Harwood; Eric - Toledo OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutically Acceptable Salts Of Quinolinone Compounds Having Improved Pharmaceutical Properties App 20140303182 - Cai; Shaopei ; et al.	2014-10-09
Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-q- uinolin-2-one lactic acid salts Grant 8,614,216 - Okhamafe , et al. December 24, 2	2013-12-24
Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties App 20130338171 - Cai; Shaopei ; et al.	2013-12-19
Pharmaceutically Acceptable Salts Of Quinolinone Compounds Having Improved Pharmaceutical Properties App 20130018058 - Cai; Shaopei ; et al.	2013-01-17
Methods For Synthesizing Quinolinone Compounds App 20120277434 - Cai; Shaopei ; et al.	2012-11-01
Crystalline And Other Forms Of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-q- Uinolin-2-one Lactic Acid Salts App 20120208825 - Okhamafe; Augustus O. ; et al.	2012-08-16
Methods for synthesizing heterocyclic compounds Grant 8,222,413 - Galvin , et al. July 17, 2	2012-07-17
Antibacterial agents Grant 8,101,640 - Andersen , et al. January 24, 2	2012-01-24
Antibacterial agents Grant 7,989,660 - Andersen , et al. August 2, 2	2011-08-02
Crystalline And Other Forms Of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-q- Uinolin-2-one Lactic Acid Salts App 20110178097 - Okhamafe; Augustus O. ; et al.	2011-07-21
Antibacterial agents App 20110172174 - Andersen; Niels H. ; et al.	2011-07-14
Methods For Synthesizing Heterocyclic Compounds. App 20110046376 - Galvin; Gabriel ; et al.	2011-02-24
Methods of treating cancer and related methods Grant 7,838,527 - Hannah , et al. November 23, 2	2010-11-23
Inhibition of FGFR3 and treatment of multiple myeloma Grant 7,825,132 - Cai , et al. November 2, 2	2010-11-02
Pharmaceutically Acceptable Salts Of Quinolinone Compounds Having Improved Pharmaceutical Properties App 20090181979 - Cai; Shaopei ; et al.	2009-07-16
Antibacterial Agents App 20080269221 - Andersen; Niels H. ; et al.	2008-10-30
Antibacterial agents App 20070244197 - Andersen; Niels H. ; et al.	2007-10-18
Inhibition of FGFR3 and treatment of multiple myeloma App 20050261307 - Cai, Shaopei ; et al.	2005-11-24
Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties App 20050209247 - Cai, Shaopei ; et al.	2005-09-22
Optimal rib design method for exhaust components Grant 6,931,367 - Harwood August 16, 2	2005-08-16
Methods for synthesizing quinolinone compounds App 20050137399 - Cai, Shaopei ; et al.	2005-06-23
Antibacterial agents App 20040229955 - Andersen, Niels H. ; et al.	2004-11-18
Methods of treating cancer and related methods App 20040220196 - Hannah, Alison ; et al.	2004-11-04
Optimal rib design method for exhaust components App 20030101030 - Harwood, Eric	2003-05-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.